US 12215355
Stem cell derived islet differentiation
granted A61KA61K2035/126A61K35/39
Quick answer
US patent 12215355 (Stem cell derived islet differentiation) held by Vertex Pharmaceuticals Incorporated expires Mon Jan 30 2045 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Vertex Pharmaceuticals Incorporated
- Grant date
- Tue Feb 04 2025 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Jan 30 2045 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 20
- CPC classes
- A61K, A61K2035/126, A61K35/39, A61P, A61P5/50